Artiva Biotherapeutics, Inc. (ARTV) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM), revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | -41.0% |
| FCF Growth (YoY) | 42.5% |
| Price / Book | 1.54 |
| Price / Sales | 19.50 |
| FCF Yield | -27.8% |
| Altman Z-Score | 2.84 (grey) |
| Sector P/E (Healthcare) | 21.7 |
ARTV overview · ARTV earnings · ARTV KPIs · ARTV investor relations · ARTV ownership · ARTV peers · ARTV filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.